We describe a case of amyloidosis localised to the bronchial tree that was treated by laser therapy. The initial diagnosis was thought to be bronchogenic squamous carcinoma. This case shows that amyloid is an unusual cause of bronchial obstruction that may simulate bronchogenic carcinoma and that in certain cases bronchoscopic laser cautery may be appropriate.
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Case report
A 39 year old woman was admitted to hospital complaining of chest pain, breathlessness, cough, and haemoptysis. She had been discharged three days previously after an ovarian cystectomy. The past medical history included a hysterectomy for an ovarian cyst complicated by a pulmonary embolus 10 years before this admission. In the intervening time she had been perfectly well. She smoked five cigarettes daily, occasionally with marijuana.
On examination she was distressed with stridor and tachypnoea (30/min) but afebrile and not cyanosed. Expansion and breath sounds were reduced over the right hemithorax. The pulse rate was 120 beats/min and blood pressure 120/80 mm Hg, and there were no signs of heart failure. Forced vital capacity (FVC) was 1.6 litres (predicted 3.85 1) FEV, was 1 litre (predicted 2.72 1) and peak expiratory flow rate (PEFR) was 200 l/min-' An electrocardiogram showed a sinus tachycardia with normal axis and QRS complex. A radiograph was normal. A ventilation-perfusion lung scan showed virtual absence of ventilation of the right lung, with normal perfusion and no abnormality of the left lung. In view of these findings bronchoscopy was performed. The vocal cords and trachea were normal but the right main bronchus was almost completely occluded by apparent submucosal infiltration and swelling. The bronchial mucosa was reddened and oozed blood between nodules of pale, malignant looking tissue. Further nodules were seen at the carina extending into the left main bronchus. Multiple biopsy specimens and bronchial washings were taken.
Microscopy of the bronchial biopsy specimens showed chronically inflammed mucosa and foci of squamous metaplasia with some infiltrating cells strongly suggestive of invasive squamous cell bronchogenic carcinoma (figure, A Microscopy of biopsy specimens again showed considerable squamous metaplasia but also a nodule of congophilic and thioflavin T positive material (figure, B). These changes are diagnostic of amyloidosis and review of the first biopsy specimens showed amyloid to be present in small amounts. Immunochemical staining showed this to contain the AL subunit protein. The urine was negative for Bence-Jones protein and a rectal biopsy specimen was negative.
An attempt at bronchoscopic removal of the obstructing tissue during rigid bronchoscopy under general anaesthetic was impeded by bleeding. The patient was referred for laser therapy to relieve the haemoptysis. Laser therapy was given twice, a neodynium-yttrium-aluminium-garnet crystal laser (Barr and Stroud Fiberlase 100) being used, to photocoagulate the sessile endobronchial lesions. After treatment the haemoptysis and breathlessness ceased. At follow up 18 months after presentation the patient's FVC (3.8 1), FEV, (2.2 1), and PEFR (234 1 min-') remained satisfactory. There has been one further episode of blood streaking the sputum, which resolved with antibiotic treatment.
Discussion
This case of primary tracheobronchial amyloid is unusual in that the onset was acute and the patient was young (the mean age at presentation being 53 years) and female, the disease being commoner in men. The diagnosis is histological, the clinical appearances being often highly suggestive of malignancy. Squamous metaplasia is a well recognised feature and a diagnostic trap histologically.2 Traditionally, amyloid has been classified as primary or secondary, but now differences in the amyloid fibrils have led to a chemical classification of clinicopathological entities. 
